Patent ID: 9701631
Date: 2017-07-11
CPC Classifications: A61K,A61P,C07D

Claim:
1. A pharmaceutical composition comprising a compound having a structure of Formula I: wherein Ar and at least one pharmaceutically acceptable carrier, diluent, excipient or auxiliary, said composition formulated in a unit dosage form suitable for oral administration, parenteral administration, rectal administration, topical administration, or vaginal administration to a mammal, wherein: (a) the dosage form suitable for oral administration is a tablet capsule or lozenge; (b) the dosage form suitable for parenteral administration comprises an aqueous solution selected from the group consisting of Hanks solution, Ringer's solution and a physiological saline buffer, and further optionally containing one or more emulsifying agents and/or suspending agents; (c) the dosage form suitable for topical administration is a gel, lotion, cream, ointment foam, skin patch, wafers, or implant; and (d) the dosage form suitable for rectal or vaginal administration is a suppository or pessary; and wherein the compound having a structure of Formula I is present in a therapeutically effective amount for treating multiple sclerosis, diabetes mellitus, rheumatoid arthritis, lupus, Crohn's disease, Hashimoto's disease, polymyositis, inflammatory bowel disease, colitis, scleroderma, oophoritis, thyroiditis, Grave's disease, dermatomyositis, Pemphigus vulgaris, myasthenia gravis, hemolytic anemia, or Sjogren's disease.